MedTrace Logo

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

NCT02955706 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2021-04-14

No results posted yet for this study

Summary

clinical trial to assess the efficacy of Acetyl-L-carnitine

Conditions

  • Alzheimer Disease

Interventions

DRUG

Acetyl-L-Carnitine

TID

DRUG

Placebo of Acetyl-L-Carnitine

TID

Sponsors & Collaborators

  • Dong-A ST Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Seol Hee Han, MD · Konkuk University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2018-09-29
Completion
2019-01-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955706 on ClinicalTrials.gov